ArticleCurrent urology reports2011
Impact of genetics on the diagnosis and treatment of renal cancer.
Article in Current urology reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 24 citations in OpenAlex.
- Thyroid Carcinoma in Birt-Hogg-Dubé Syndrome: Case Series and Review of Literature.Thyroid : official journal of the American Thyroid Association · 2025Review
- Skeletal muscle of young females under resistance exercise exhibits a unique innate immune cell infiltration profile compared to males and elderly individuals.Journal of muscle research and cell motility · 2024Article
- Glia Maturation Factor β as a Novel Independent Prognostic Biomarker and Potential Therapeutic Target of Kidney Renal Clear Cell Carcinoma.Frontiers in oncology · 2022Article
- Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management.Seminars in ultrasound, CT, and MR · 2017Review
- Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.Familial cancer · 2016Article
- Article
- Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.The Journal of urology · 2012Article
- Optical property measurements establish the feasibility of photodynamic therapy as a minimally invasive intervention for tumors of the kidney.Journal of biomedical optics · 2012Article
- Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome.Familial cancer · 2012Article
- Relevant Networks involving the p53 Signalling Pathway in Renal Cell Carcinoma.International journal of biomedical science : IJBS · 2011Article
- Familial renal cancer: molecular genetics and surgical management.International journal of surgical oncology · 2011Article
- Epidemiological profile of kidney cancer in Brazil: a multiregional ecological study.Jornal brasileiro de nefrologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
Kidney cancer is a heterogeneous disease comprised of a number of histologic subtypes, each associated with unique genetic mutations, clinical features, and sensitivity to treatment. By examining families affected with the hereditary kidney cancer syndromes von Hippel-Lindau, hereditary papillary renal cell carcinoma, hereditary leiomyomatosis and renal cell carcinoma, and Birt-Hogg-Dubé, researchers have been able to identify the genes responsible for these syndromes. This work has revealed that kidney cancer is fundamentally a metabolic disorder, and as such, novel targeted therapies specific to their molecular biology have been developed and employed in both the hereditary and sporadic forms of renal cell carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.